Engineering a Cell-Free Murein Biosynthetic Pathway: Combinatorial Enzymology in Drug Discovery
- 1 December 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 120 (51), 13527-13528
- https://doi.org/10.1021/ja983468z
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Inhibitors of the bacterial cell wall biosynthesis enzyme Mur DBioorganic & Medicinal Chemistry Letters, 1998
- Invariant Amino Acids in the Mur Peptide Synthetases of Bacterial Peptidoglycan Synthesis and Their Modification by Site-Directed Mutagenesis in the UDP-MurNAc:l-Alanine Ligase from Escherichia coliBiochemistry, 1997
- High-Level Expression of Soluble Protein inEscherichia coliUsing a His6-Tag and Maltose-Binding-Protein Double-Affinity Fusion SystemProtein Expression and Purification, 1997
- Conditionally Lethal Escherichia coli Murein Mutants Contain Point Defects That Map to Regions Conserved among Murein and Folyl Poly-γ-glutamate Ligases: Identification of a Ligase SuperfamilyBiochemistry, 1997
- Overexpression, purification, and characterization of UDP-N-acetylmuramyl:L-alanine ligase from Escherichia coliJournal of Bacteriology, 1996
- The Discovery of Cell Wall Active Antibacterial AntibioticsCritical Reviews in Biotechnology, 1992